Treatment of FANCA cells with resveratrol and N-acetylcysteine: A comparative study

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Columbaro, Marta ^a   Ravera, Silvia ^b   Capanni, Cristina ^c   Panfoli, Isabella ^b   Cuccarolo, Paola ^d   Stroppiana, Giorgia ^e   Degan, Paolo ^d   Cappell, Enrico ^e  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; FANCONI ANEMIA GROUP A PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; RESVERATROL; ANTIOXIDANT; STILBENE DERIVATIVE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMETRY; ELECTRON MICROSCOPY; ELECTRON TRANSPORT; ENZYME ACTIVITY; FANCONI ANEMIA; GENOTYPE; HUMAN; HUMAN CELL; LYMPHOCYTE; MITOCHONDRIAL RESPIRATION; OXYGEN CONSUMPTION; PHENOTYPE; TREATMENT FAILURE; ULTRASTRUCTURE; CELL CULTURE; DRUG SCREENING; METABOLISM; MITOCHONDRION; PATHOLOGY;

ACETYLCYSTEINE; ANTIOXIDANTS; CELLS, CULTURED; DRUG EVALUATION, PRECLINICAL; FANCONI ANEMIA; HUMANS; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 84937449883     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104857     Document Type: Article

References (25)

1. Li X, Yang Y, Yuan J, Hong P, Freie B et al. (2004) Continuous in vivo infusion of interferon-gamma (IFN-gamma) preferentially reduces myeloid progenitor numbers and enhances engraftment of syngeneic wild-type cells in Fancc-/- mice. Blood 104: 1204-1209. (Pubitemid 39038045)
2. Capanni C, Bruschi M, Columbaro M, Cuccarolo P, Ravera S et al. (2013) Changes in vimentin, lamin A/C and mitofilin induce aberrant cell organization in fibroblasts from Fanconi anemia complementation group A (FA-A) patients. Biochimie 95: 1838-47.
3. Ravera S, Vaccaro D, Cuccarolo P, Columbaro M, Capanni C et al. (2013) Mitochondrial respiratory chain Complex I defects in Fanconi anemia complementation group A. Biochimie 95: 1828-1837.
4. Cappelli E, Ravera S, Vaccaro D, Cuccarolo P, Bartolucci M et al. (2013) Mitochondrial respiratory complex I defects in Fanconi anemia. Trends Mol Med 19: 513-514.
5. Dodd S, Dean O, Copolov DL, Malhi GS, Berk M (2008) N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opinion on Biological Therapy 8: 1955-1962.
6. Dong Z (2003) Molecular mechanism of the chemopreventive effect of resveratrol. Mutat Res. 523-524: 145-50.
7. Csiszar A (2011) Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease. Ann N Y AcadSci 1215: 117-22.
8. Gledhill JR, Montgomery MG, Leslie AG, Walker JE (2007) Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols. Proc Natl Acad Sci U S A. 104: 13632-7. (Pubitemid 350003372)
9. Ponte F, Sousa R, Fernandes AP, Gonçalves C, Barbot J et al. (2012) Improvement of genetic stability in lymphocytes from Fanconi anemia patients through the combined effect of α-lipoic acid and N-acetylcysteine. Orphanet J Rare Dis 16: 7-28.
10. Zhang QS, Marquez-Loza L, Sheehan AM, Watanabe-Smith K, Eaton L et al. (2014) Evaluation of resveratrol and N-acetylcysteine for cancer chemoprevention in a Fanconi anemia murine model. Pediatr Blood Cancer. 61: 740-742.
11. Roomi MW, Kalinovsky T, Roomi NW, Niedzwiecki A, Rath M (2012) In vitro and in vivo inhibition of human Fanconi anemia-associated head and neck squamous cell carcinoma by a novel nutrient mixture. Int J Oncol. 41: 1996-2004.
12. Hanenberg H, Batish SD, Pollok KE, Vieten L, Verlander PC et al. (2002) Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool. Exp Hematol. 30: 410-20. (Pubitemid 34556732)
13. Ravera S, Panfoli I, Calzia D, Aluigi MG, Bianchini P et al. (2009) Evidence for aerobic ATP synthesis in isolated myelin vesicles. Int J Biochem Cell Biol.41: 1581-1591.
14. Ravera S, Calzia D, Bianchini P, Diaspro A, Panfoli I (2007) Confocal laser scanning microscopy of retinal rod outer segment intact disks: new labeling technique. J Biomed Opt.12: 050501.
15. Bergmeyer HU, Grassl M, Walter HE (1983) Methods of Enzymatic Analysis, Verlag-Chemie, Weinheim,p. 249.
16. Hong SM, Pedersen PL (2008) ATP Synthase and the Actions of Inhibitors Utilized To Study Its Roles in Human Health, Disease, and Other Scientific Areas. Microbiol Mol Biol Rev 72: 590-641.
17. Zheng J, Ramirez VD (2000) Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br. J. Pharmacol 130: 1115-1123. (Pubitemid 30453547)
18. Jangamreddy JR, Los MJ (2012) Mitoptosis, a novel mitochondrial death mechanism leading predominantly to activation of autophagy. Hepat Mon. 12(8):e6159.
19. Castella M, Pujol R, Callén E, Trujillo JP, Casado JA et al. (2011) Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations. Blood 117: 3759-69.
20. Kumari U, Ya Jun W, Huat Bay B, Lyakhovich A (2014) Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi Anemia cells. Oncogene 33: 165-172.
21. Cuccarolo P, Viaggi S, Degan P (2012) New insights into redox response modulation in Fanconi's anemia cells by hydrogen peroxide and glutathione depletors. FEBS J. 279: 2479-94.
22. Zhang H, Limphong P, Pieper J, Liu Q, Rodesch CK et al. (2012) Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity. FASEB J. 26: 1442-51.
23. Pletjushkina OY, Lyamzaev KG, Popova EN, Nepryakhina OK, Ivanova OY et al. (2006) Effect of oxidative stress on dynamics of mitochondrial reticulum. BiochimBiophysActa. 1757: 518-24. (Pubitemid 43996946)
24. Low IC, Chen ZX, Pervaiz S. (2010) Bcl-2 modulates resveratrol-induced ROS production by regulating mitochondrial respiration in tumor cells. Antioxid. Redox Signal. 13, 807-819.
25. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C et al. (2006) Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α. Cell, 127, 1109-1122. (Pubitemid 44894520)